Related Experiment Video
Updated: May 7, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Maternal methadone dose during pregnancy and infant clinical outcome: response to O'Grady et al
Trecia A Wouldes1, Lianne J Woodward
1Department of Psychological Medicine, Faculty of Medical and Health Science, University of Auckland, Auckland 1142, New Zealand.
We agree with O'Grady et al. (2013) that the relationships between maternal methadone dose during pregnancy and neonatal outcomes deserve serious attention. However, we would also argue that a broader range of infant health and neurobehavioral outcomes need to be considered, not only in the short but also the longer term.
We agree with O'Grady et al. (2013) that the relationships between maternal methadone dose during pregnancy and neonatal outcomes deserve serious attention. However, we would also argue that a broader range of infant health and neurobehavioral outcomes need to be considered, not only in the short but also the longer term.
More Related Videos
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children
Teratogenicity
Pharmacokinetics in Pediatric Patients: Drug Excretion